Skip to main content

DNB Asset Management AS

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1456670 Oslo, Q8

Position in ALNY

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$16,278,498
+$5,880,247 QoQ
Shares Held
54,076
+72.1% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#148
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DNB Asset Management AS holds $308,807,747 across 74 Biotechnology names. ALNY ranks #6 (5.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
6 ALNY
Alnylam Pharmaceuticals, Inc.
This page
54,076 $16,278,498

All Filings in ALNY

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,278,498 54,076
2026-03-31 $10,398,251 31,427
2025-12-31 $12,210,638 30,707
2025-09-30 $15,626,208 34,268
2025-06-30 $8,955,409 27,463
2025-03-31 $7,370,735 27,297
2024-12-31 $6,290,542 26,733
2024-09-30 $6,985,211 25,398
2024-06-30 $6,321,645 26,015
2024-03-31 $3,735,203 24,993
2023-12-31 $8,847,735 46,224
2023-09-30 $9,069,645 51,212
2023-06-30 $4,808,141 25,314
2023-03-31 $4,671,061 23,318
2022-12-31 $5,275,117 22,197
2022-09-30 $4,199,957 20,983
2022-06-30 $3,095,957 21,227
2022-03-31 $3,487,057 21,355
2021-12-31 $3,304,605 19,487
2021-09-30 $3,364,027 17,817
2021-06-30 $3,038,646 17,925
2021-03-31 $3,301,869 23,386
2020-12-31 $2,047,937 15,757
2020-09-30 $1,956,136 13,435
2020-06-30 $2,001,410 13,513
2020-03-31 $1,151,088 10,575